(Q53599876)

16 May 2018

title

Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. (English)

1 reference

16 May 2018

1 reference

Amer Rajab

1

1 reference

16 May 2018

Ronald P Pelletier

series ordinal

2

1 reference

16 May 2018

Mitchell L Henry

series ordinal

3

1 reference

16 May 2018

Ronald M Ferguson

series ordinal

4

1 reference

16 May 2018

publication date

1 September 2006

1 reference

16 May 2018

published in

Clinical Transplantation

1 reference

16 May 2018

volume

20

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

537-546

1 reference

16 May 2018

Renal transplant recipient attitudes toward steroid use and steroid withdrawal

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Preclinical results of sirolimus treatment in transplant models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Metabolic interaction between cyclosporine and sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Evolution of the therapeutic drug monitoring of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Pharmacologic monitoring and outcomes of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

New concepts in cyclosporine monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Conversion to C2 monitoring of cyclosporine A exposure in maintenance kidney transplant recipients: results at 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

C2 monitoring in maintenance renal transplant recipients: is it worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00521.X

10.1111/J.1399-0012.2006.00521.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018